We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Guangzhou Pluslife Biotech Co., Ltd.

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Global Critical Care Diagnostics Market Driven by Rising Expenditure in ICUs and Emergency Rooms

By LabMedica International staff writers
Posted on 12 Oct 2022
Print article
Image: The global critical care diagnostics market is expected to reach USD 1.7 billion in 2031 (Photo courtesy of Pexels)
Image: The global critical care diagnostics market is expected to reach USD 1.7 billion in 2031 (Photo courtesy of Pexels)

Critical care diagnostics tests have become essential solutions for patients dealing with life-threatening conditions, which especially require sophisticated invasive monitoring devices alongside other monitoring and life support systems. They are cost-effective and easy to use while providing accurate diagnosis and significantly reducing therapeutic turnaround. The global critical care diagnostics market was valued at USD 1.1 billion in 2020 and is projected to register a CAGR of 5.5% from 2021 to 2031 to reach USD 1.7 billion in 2031, driven mainly by the rising adoption of critical care diagnostic tests across operating rooms, emergency rooms, and intensive care units for meeting the needs of critically ill patients who require immediate attention.

These are the latest findings by Fact.MR (Rockville, MD, USA), a market research and consulting agency.

The growing demand for rapid diagnosis and treatment will continue to drive sales of critical care diagnostic products in the market. Similarly, growing awareness of these tests among physicians and patients, as well as their associated advantages, a rapidly growing geriatric population, and increase in the frequency of chronic diseases such as diabetes, heart disease, and cancer will drive the growth of the critical care diagnostics market over the forecast period. Demand is also being driven by the increasing adoption of telehealth services and remote communications. Rising usage of data management and connectivity through interoperability to electronic health records (EHR) will further boost market growth. However, the high cost of molecular diagnostics and lack of skilled professionals are expected to hamper the growth of the global critical care diagnostics market.

Based on test, the hematology tests segment accounts for a share of 40% of the critical care diagnostics market and is projected to grow at a CAGR of 5% through 2032. Based on end users, the emergency room segment is predicted to register the fastest growth over the forecast period due to rising demand for emergency services from patients seeking rapid medical attention. Patients can also receive emergency treatment without prior appointment and obtain basic life support in the event of severe traumatic situations. As the survival rate of critically ill patients in the emergency department is directly related to the advancement of early recognition and treatment of diseases, the demand for critical care diagnostics will grow at a significant pace in this segment.

Geographically, North America will continue to dominate the global critical care diagnostics market and account for around half of its total revenues due to considerable research and development efforts, and increased use of numerous tests by clinicians in the region. Within North America, the U.S. critical care diagnostics market was valued at around USD 290 million in 2020 and it is expected to grow at a steady pace over the next decade. Continuous advancements in diagnostic technologies are expected to create lucrative growth opportunities for the leading players in the critical care diagnostics market during the forecast period.

Related Links:
Fact.MR 

New
Gold Supplier
Group A Streptococcus Antigen Test
OSOM Strep A Test
New
Silver Supplier
Monkeypox Virus Real Time PCR Test
Monkeypox Virus Real Time PCR Detection Kit
New
STI Detection Test
NeoPlex STI-7 Detection Kit
New
Rapid Immunological FOB Test
Fecal Occult Blood Test

Print article
SUGENTECH INC.

Channels

Clinical Chem.

view channel
Image: ELISA kit for liver-type fatty acid–binding protein (L-FABP). The level of L-FABP present in urine reflects the level of renal tubular dysfunction (Photo courtesy of Sekisui Medical Co)

Urinary Biomarkers Predict Weaning From Acute Dialysis Therapy

Acute kidney injury is associated with a higher risk of chronic kidney disease (CKD), end-stage renal disease, and long-term adverse cardiovascular effects. Critically ill patients with acute kidney injury... Read more

Microbiology

view channel
Image: Ring-form trophozoites of Plasmodium vivax in a thin blood smear (Photo courtesy of Centers for Disease Control and Prevention)

Immune Regulators Predict Severity of Plasmodium vivax Malaria

Cytokines and chemokines are immune response molecules that display diverse functions, such as inflammation and immune regulation. In Plasmodium vivax infections, the uncontrolled production of these molecules... Read more

Pathology

view channel
Image: Breast cancer spread uncovered by new molecular microscopy (Photo courtesy of Wellcome Sanger Institute)

New Molecular Microscopy Tool Uncovers Breast Cancer Spread

Breast cancer commonly starts when cells start to grow uncontrollably, often due to mutations in the cells. Overtime the tumor becomes a patchwork of cells, called cancer clones, each with different mutations.... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.